[18F]-A20FMDV2

· Queen Mary University of London

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for [18F]-A20FMDV2, covering 2024-07-08 to 2024-07-08. Get the full timeline:

Most recent: Clinical Trial Update: IMaging Pilot Study of the αvβ6 Integrin Radiotracer [18F]-A20FMDV2 in PAtients With Solid Cancer Types [NA]